id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-349533-51cex2sl	Yeoh, Su-Ann	Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?	2020-06-08		.txt	text/plain	1597	79	43	title: Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic? Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic? 1 This strategy was first tested through randomised clini cal trials, and was then assessed in clinical practice, initially in patients with early rheumatoid arthritis and subsequently in those with established disease. Translational and clinical research in the field of rheumatology has produced several, novel biological therapies, has helped to improve remission rates through the application of treat-to-target methods, and is needed to guide tapering strategies. The COVID-19 pandemic offers the oppor tunity to test the usefulness of patient-reported outcomes and web-based monitoring applications to aid in the remote management of patients with rheumatoid arthritis. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice	./cache/cord-349533-51cex2sl.txt	./txt/cord-349533-51cex2sl.txt